Pfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Pfizer Inc. expects demand for its Covid-19 antiviral drug to increase as governments return to replenish their supplies and seek to thwart surges as the pandemic virus continues to evolve.
The treatment, a pill called Paxlovid, brought in $1.5 billion in sales during Pfizer’s first quarter, while its vaccine totaled $13.2 billion, reflecting the need forTo Read the Full Story
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Consulte Mais informação »
Amazon ends its paid Covid-19 sick leave policyThe return to pre-pandemic sick leave policies means that all US Amazon employees will now get up to five days of excused, unpaid time off for a confirmed Covid-19 diagnosis.
Consulte Mais informação »
CDC moves tourism hot spot out of 'high' risk level for Covid-19The US Centers for Disease Control and Prevention lowered the Covid-19 travel risk for one of the most popular destinations in the Western Hemisphere on Monday.
Consulte Mais informação »
What happens if I get COVID-19 while traveling?COVID-19 rules for travelers will vary depending on the destination. But testing positive for the virus could result in an unexpected change in plans, such as being required to stay isolated in a hoteI.
Consulte Mais informação »
LA County health officials urge workplace safety as COVID-19 spread continuesHealth officials have been reporting elevated daily case numbers in recent weeks, attributable largely to the BA.2 subvariant of the virus. An offshoot of that variant -- known as BA.2.12.1 -- has also begun spreading locally, and health officials said it is believed to be 20% to 30% more infectious than BA.2.
Consulte Mais informação »
COVID-19 Cases and Pollen Count Both Climbing, Leaving Those With the Sniffles WonderingPatients are presenting with stuffy nose, nasal congestion, cough, post-nasal drip and sore throats. In the age of COVID, that leaves people worried.
Consulte Mais informação »